Wholesale USA peptides.
From inside the industry.
the next lab is the wholesale arm of a working research-peptide operation — we run our own RUO brand on the same supply. We sell two ways: wholesale by the case, or dropshipped under the buyer's own label — we print the labels, hold the stock, pack every order, and ship from our warehouse in Los Angeles. This desk is your reference: what we sell, what it costs, and how to talk about it.
"We're peptide people — we run our own research-use brand, so we know what resellers deal with: suppliers that dry up, product that never saw a lab, no paperwork when a customer asks questions. Our wholesale side sells the same supply we use ourselves — shipped from the US, third-party COA on every batch, lot-tracked. And if you don't want to hold inventory, we put your label on it and ship your orders from our warehouse in LA. No minimums. Start with one case, read the COAs, and decide from there."
Everything we sell is Research Use Only — not for human consumption. Never claim or imply human use, dosing, or benefit — in writing, on calls, anywhere. The full non-negotiables are in Sell it. Compliance is the moat that keeps our doors open and your commissions flowing.
The industry, honestly.
You're selling into a market with real, specific problems. Learn them — every one of them is the reason a buyer picks up the phone.
- Most supply is untested gray-market import. No third-party testing, no lot tracking, no paperwork when a customer asks. Buyers know this — it's their single biggest anxiety, and it's why a COA library closes deals.
- The category can't run mainstream paid ads. Brands grow on communities, organic, and email — so a brand's reputation is its entire acquisition engine. One bad batch is existential for them. That's the fear you're actually selling against.
- Payments are fragile. Card processors routinely drop peptide merchants. At wholesale, wire/ACH invoicing is the norm — nobody serious is asking to run a card.
- September 2025: FDA warning letters went to sellers marketing RUO peptides with human-use implications — BPC-157 and GLP compounds included. The letters targeted the marketing language, not the molecules. Sloppy copy got hit; disciplined RUO sellers didn't. That's why our compliance line is absolute.
- We operate in this category ourselves. Our own RUO brand runs on the same factory relationship, the same per-batch COAs, the same LA fulfillment. The wholesale arm sells what we already use — we're operators, not brokers flipping vials.
- The big wholesale books gate pricing behind committed volume. Per the July 2026 schedules: the in-stock lane starts at $25K monthly committed with rebate true-ups; the cheaper lane is made-to-order — COD with a 30–50% production deposit and a 2–4 week lead.
- Our book has one tier and it starts at case one. On the flagship SKUs we run roughly 45–65% under their $25K entry pricing — in stock, no deposit, no lead time, no true-up math.
- The honest exception: Epithalon 50mg — the committed books run it below our cost, so we lose that one on price. Don't lead with it; lead with the other 73 SKUs.
This is the biggest wellness wave in a decade, and it's early. The reps who grow accounts fastest are the ones who can show a buyer where the money is actually going — and why sitting still is the expensive choice.
The account that orders one hero SKU is leaving money on the table while the wave is cresting. The move is to widen the SKU mix [metabolic pulls them in; recovery and longevity are the repeat-margin attach] and put them on a standing order so they never go dry mid-wave. Frame it as theirs to lose: "the demand is already in your audience — the only question is whether they buy it from you or from someone with worse supply. Let's make sure you're never the one out of stock."
Market figures are directional [analyst consensus, branded-drug category] — use them to size the opportunity, never as a claim about our product. Everything we sell stays RUO.
That's the whole sell: a category the market is pouring money into, tested supply that's in stock with no commitment, sold by people inside the industry. You don't need to hype anything — the demand and the buyer's own problems do the talking. Your job is to know both better than they do.
Two ways to buy.
Wholesale cases are the business. Dropship is how brands without infrastructure get in. That's it — two lanes, one price book, no packages.
Cases of 10
- Case of 10 vials · per-vial equivalent from $8.50
- No MOQs, no volume commitments — one book, starts at case one
- COA + lot tracking on every batch
- Freight at cost, confirmed at order review
White-label · we fulfill
- Priced per vial + flat $5/vial fulfillment — quote the all-in number
- We print matte waterproof labels with their branding
- Connects to their WooCommerce store — orders flow to us
- No stock, no packing, no shipping on their side
Most accounts end up running both. Dropship while they build demand; cases once the volume makes the math obvious. Either way the account lives in the portal and reorders monthly — reorders are the business, not the first sale.
MAP protects their margin — say it plainly. We hold a minimum advertised price policy on resale [no advertised resale below 2× the wholesale per-vial equivalent]. It means we're not letting their competitors race them to the bottom on the same supply.
Price book — standard 15% tier
This is the standard book. Every account gets its own live, confidential pricing inside the portal — always quote from the portal, never improvise. Use this table to talk ranges and value fast.
The GLP metabolic line [GLP-1 · GLP-2 · GLP-3] is the traffic driver — highest-volume category in the market. BPC-157 and CJC+IPA are the recovery staples with the most loyal reorder behavior. Longevity [NAD+, GHK-Cu, Epithalon, MOTS-C] is the best-margin category. BAC water attaches to nearly every order.
What the codes are [internal + B2B]: GLP-1 = semaglutide · GLP-2 = tirzepatide · GLP-3 = retatrutide. You can use the molecule names with buyers and in these docs — it's a research-compound conversation between businesses. The line that never moves: never pair a molecule with a human-use, dosing, or benefit claim — that's what the FDA letters hit, not the name itself. Our public storefront still shows codes only [brand-discretion, not a rule for you].
Dropship — no stock needed.
The buyer never touches a vial. We connect to their store, print their labels, and ship every retail order from our Los Angeles warehouse under their brand. They run the audience; we run the back end.
Dropship is priced per vial, and higher than the case rate, plus a flat $5/vial fulfillment fee covering label print, pick, pack, and dispatch. The all-in per-vial number is what you quote — it's in the price book above, per account, in the portal.
Say it straight: "Per vial it costs more than a case — that's the price of holding zero inventory and doing zero ops. Most brands start here, then graduate to wholesale cases as volume grows and their per-unit cost drops."
Toggle the price book above to Dropship for every all-in per-vial number.
Their customer pays them retail; we bill them the all-in vial price per order shipped. No stock risk, margin on every sale from day one.
Who this fits: creators and coaches with real audiences, supplement founders who want a peptide line, e-commerce operators who know their numbers — anyone with demand but no infrastructure. The honest opener is "you never buy inventory". Wholesale comes later, when their volume earns it.
Ship & pack — what buyers get.
Fulfillment is part of the pitch. Product is shelf-stable lyophilised vials — no cold chain drama — packed to survive and to look professional out of the box.
We dropship from our warehouse in Los Angeles. If they ask for the address: 500 N Central Ave, Los Angeles, CA. Don't volunteer it unprompted — but never dodge the question either; a straight answer builds trust.
Case freight ships at cost and is confirmed at order review — no markup, no surprises. It's on the invoice before anything ships.
Postage at cost; the $5/vial fulfillment fee covers label print, pick, pack, and materials. Their customers get tracked, discreet, padded delivery.
Sell it — rules, targets, scripts.
The non-negotiables — read twice
- Sell to businesses, for resale as research material. Every conversation B2B, research-framed.
- Qualify the buyer as a real brand, reseller, or research-affiliated business — never personal use.
- Lead with supply, testing, compliance — COA per batch, lot tracking, labeling, fulfillment.
- Keep language scientific and commercial — SKUs, purity, margin, turnaround.
- Route human-use questions to your manager.
- Never claim or imply human use, benefit, or consumption.
- Never give dosing, administration, or reconstitution-for-use guidance. Analytical specs only.
- Never make therapeutic claims — no treats, prevents, cures.
- Never compare our product to an approved drug as a substitute.
- Never use testimonials or before/after stories.
- Never pair a molecule name with a human-use, dosing, or benefit claim — the name itself is fine in B2B; the claim is the violation.
The one-sentence test: "Does anything here suggest a person will take this product?" If yes — rewrite. If unsure — manager first. When in doubt, leave it out.
"I have to stop you there — everything we supply is research-use-only, so I genuinely can't advise on human use, and honestly a supplier who would is a red flag. What I can do is get you the full COA and analytical specs so your team has the data. Fair?"
Who you sell to — spend your time top-down
First 90 days: ~60% Tier 1 · ~30% Tiers 2–4 · ~10% the rest. Tier 1 = shortest cycle, biggest volume, fastest reorders. Tiers 2 & 5–6 are your dropship conversations — audience, no infrastructure. International: qualify, capture, hand to your manager — never close solo.
Openers that work — personalize every one
Subject: Better peptide supply for [Brand]
Hi [Name],
I run B2B supply for the next lab — we wholesale RUO research peptides with a COA on every batch and US-based fulfillment out of Los Angeles. I came across [Brand] and thought our supply might be a fit.
Most brands come to us for one of three reasons: inconsistent stock on hero SKUs, no per-batch third-party testing, or wholesale pricing — with no MOQs — that finally protects their margin.
Worth a quick look at our catalog and your live pricing in the portal?
Hey [Name] — love what you've built with [audience]. Quick one: we help creators launch their own research-peptide line without touching the ops. Your brand on tested product — we print the labels, hold the stock, and dropship every order from our LA warehouse. You never buy inventory. If you've ever thought about your own line, I'd love to show you how it works. No pressure either way.
Opener: "Thanks for the time. My goal today is just to understand your business and see if we're a fit — no hard pitch. Walk me through what you're selling now and where supply or fulfillment has been a headache?"
What are you selling today, and who's your customer? · Where are you sourcing now, and what's frustrating? · Do you get a COA on every batch currently? · Rough monthly volume [or audience size]? · If you could fix one operational thing, what would it be? · Who else is involved in a decision like this?
Objections — tap to open
"Your price is higher than [vendor]."
"I already have a supplier."
"How do I know your product is legit?"
"Is this legal?"
"I don't want to touch fulfillment or hold stock."
"What's the minimum order?"
"Why is dropship more per vial than wholesale?"
"Let me think about it."
"Can you ship internationally?"
The portal — how buyers onboard.
The wholesale portal at portal.thenextlab.co is invite-only, and it is the onboarding experience. Know it cold — walking a buyer through it is a close in itself.
- Live price book [per-account, watermarked PDF] — your leave-behind.
- COA library — the proof; share it before they spend a dollar.
- Terms of sale — RUO obligations, payment, MAP, freight, returns.
- Fulfillment page for the dropship conversation.
- Book a call — the scheduling link for discovery and kickoff.
We invoice on approval; payment is wire or ACH. New accounts prepay until terms are extended in writing — no cards, no net-30 on day one. Freight on cases confirmed at review. Say it plainly; serious operators respect it.
The whole model runs on reorders. An account that reorders monthly beats any one-time buyer. Your job doesn't end at the close — it starts there. Standing orders are your highest-leverage move.
FAQ — answers you give buyers.
Where do you ship from?
Is there a minimum order?
Who prints the labels?
How is it packed?
How do I verify quality?
How do buyers pay?
What about returns?
Can my buyer resell at any price?
Do you ship internationally?
Goal: pipeline built, first discovery calls booked, zero compliance missteps.
Goal: first revenue on the board; a repeatable rhythm.
Goal: recurring residual income; predictable weekly pipeline.
Weighted toward residual income — you get paid every month an account keeps buying [activation % on the first order + residual % on reorders + flat bonus on white-label signings]. Exact numbers are in your rep agreement — confirm the live plan with your manager; commissions pay on collected revenue only, and compliance is a condition of getting paid.
Nothing on this page authorizes any human-use, dosing, or therapeutic claim. All products are Research Use Only — not for human consumption.
Live per-account pricing lives at portal.thenextlab.co — always quote from the portal.